Fertility protection of women in cancer;Fertilitätsprotektion bei onkologischen erkrankungen der frau

Journal fur Reproduktionsmedizin und Endokrinologie

Volumn 6, Issue 2, 2009, Pages 52-57

  Von Wolff, M ^a   Strowitzki, T ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cancer; Chemotherapy; Fertility preservation; GnRH analogous; Infertility; Oocyte; Ovarian tissue

Indexed keywords

FOLLITROPIN; GESTAGEN; GONADORELIN ANTAGONIST; GONADORELIN DERIVATIVE; TRIPTORELIN;

AMENORRHEA; BLEEDING; CANCER SURVIVAL; CANCER THERAPY; COUNSELING; CRYOPRESERVATION; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; HORMONAL REGULATION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MEDICAL SPECIALIST; OOCYTE; OVARY; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION; PREMATURE OVARIAN FAILURE; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; REPRODUCTION; REVIEW; TUMOR GROWTH;

EID: 65549159259     PISSN: 18102107     EISSN: 18109292     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Krebs in Deutschland, Arbeitsgemeinschaft Bevölkerungs-bezogener Krebsregister in Deutschland. 3. erweiterte, aktuali-sierte Ausgabe. hrsg. von der Gesellschaft der epidemiologi-schen Krebsregister in Deutschland e.V.; Robert-Koch-Institut, Saarbrücken, 2002.
2. Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer 1999; 86: 697-709.
3. Ferti PROTEKT. Website of the "Network for fertility preservation in radio-and chemotherapy", www.fertiprotekt.eu. Responsible webmaster: von Wolff, M. Installed 01' 2007, most recent update 09' 2008.
4. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod 2003; 18: 117-21.
5. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum FR. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045-52.
6. Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer 1989; 43: 399-402.
7. Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 2003; 88: 5307-14.
8. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 364: 1405-10.
9. Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, Schiff E, Dor J. Pregnancy after transplantation of cryo-preserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005; 353: 318-21.
10. Andersen CY, Rosendahl M, Byskov AG, Loft A, Ottosen C, Dueholm M, Schmidt KL, Andersen AN, Ernst E. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod 2008; 23: 2266-72.
11. Blumenfeld Z, von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 2008; 14: 543-52.
12. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006; 91: 3885-90.
13. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 2006; 86: 70-80.
14. Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril 2009; 91: 365-71.
15. Griesinger G, von Otte S, Schroer A, Ludwig AK, Diedrich K, Al-Hasani S, Schultze-Mosgau A. Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Hum Reprod 2007; 22: 1348-52.
16. von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Strowitzki T. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 2008 [Epub ahead of print].
17. von Wolff M, Strowitzki T, van der Ven H, Montag M. In vitro maturation is an efficient technique to generate oocytes and should be considered in combination with cryopreservation of ovarian tissue for preservation of fertility in women. J Clin Oncol 2006; 24: 5336-7.
18. Cha KY, Han SY, Chung HM, Choi DH, Lim JM, Lee WS, Ko JJ, Yoon TK. Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome. Fertil Steril 2000; 73: 978-83.